At a glance
- Incoterms
- FOB, FCA, CIF, CIP, DAP
India's active pharmaceutical ingredients & intermediates export trade
India exported US$4,870 mn of bulk drugs & drug intermediates in FY2024-25 according to pharmexcil.com. That statistical line covers more than active pharmaceutical ingredients & intermediates; a product-level figure is not published.
Largest destinations by value share: unavailable by country
Export markets we serve
| Market | What matters there | Sea transit from India |
|---|---|---|
| Germany | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 21-27 via Suez; 31-38 via Cape days |
| Netherlands | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 18-24 via Suez; 28-35 via Cape days |
| France | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 20–25 d to Le Havre; 15–20 d to Marseille-Fos (ASSUMPTION — this file's analyst estimate, not in 06 §F.2: typical liner schedules) |
| Italy | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 15–20 d to Genoa/La Spezia via Suez (ASSUMPTION — this file's analyst estimate, not in 06 §F.2: typical liner schedules) |
| Spain | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 15–20 d to Valencia/Barcelona/Algeciras via Suez (ASSUMPTION — this file's analyst estimate, not in 06 §F.2: typical liner schedules) |
| United States | Drug approval & facility (FDA) | 24-30 via Suez; 32-40 via Cape days |
| Canada | General import clearance | 26-34 via Suez; 34-42 via Cape days |
| Belgium | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 19-25 via Suez; 29-36 via Cape days |
| Poland | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 28–35 d to Gdańsk (direct Asia–Baltic loops or via Hamburg/Rotterdam feeder) (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Sweden | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 28–35 d to Gothenburg via Hamburg/Rotterdam feeder (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Denmark | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 28–35 d to Aarhus/Copenhagen via Hamburg feeder (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Ireland | REACH (ECHA); Classification & SDS (ECHA (CLP 1272/2008)) | 25–32 d to Dublin via Rotterdam/Antwerp/UK feeder (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Japan | General import clearance | 18–25 d to Tokyo/Yokohama/Kobe via Singapore (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| South Korea | General import clearance | 16–22 d to Busan via Singapore (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| China | General import clearance | 14–20 d to Shanghai/Ningbo; 12–16 d to Shenzhen via Singapore/Colombo (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Turkey | General import clearance | 15–22 d to Ambarlı/Istanbul; 14–20 d to Mersin via Suez (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Israel | General import clearance | 12–18 d to Haifa/Ashdod via Suez; Eilat via Red Sea (ASSUMPTION — this file's analyst estimate, not in 06 §F.2; Red Sea security situation affects routing) |
| Brazil | General import clearance | 30–40 d to Santos via Cape/Durban or Suez–Med transhipment (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
| Mexico | General import clearance | 35–45 d to Manzanillo (transpacific via Singapore/Busan) or Veracruz (via Atlantic) (ASSUMPTION — this file's analyst estimate, not in 06 §F.2) |
Transit times are typical port-to-port estimates; regulatory items are the main product-specific requirements, not an exhaustive list.
Where active pharmaceutical ingredients & intermediates is sourced in India
Telangana — Hyderabad, Sangareddy, Medak. Pashamylaram, Bollaram, Jeedimetla
Andhra Pradesh — Visakhapatnam. JN Pharma City, Parawada
Gujarat — Bharuch, Vadodara, Ahmedabad. Ankleshwar, Jhagadia, Panoli
Maharashtra — Raigad, Palghar. Tarapur, Mahad
- Guntur (Asia's largest chilli yard) / Byadgi (Andhra Pradesh; Telangana; Karnataka; MP) · ships via Chennai · season: Harvest Jan-Apr; cold-storage stock traded year-round (ASSUMPTION)
Typical export specification
| Parameter | Typical value |
|---|---|
| Assay | Per monograph, commonly 98.0-102.0% on dried/anhydrous basis (typical) |
| Related substances | Per USP/Ph. Eur./IP monograph or buyer specification (typical) |
| Residual solvents | Within ICH Q3C limits (typical) |
| Nitrosamine risk assessment | Provided on request for relevant molecules (typical) |
| Particle size | Micronised or as-is per buyer specification, e.g. D90 < 10 µm on request (typical) |
Agreed per contract and confirmed by lab report or pre-shipment inspection.
Export documentation
Documents we prepare or arrange for each shipment:
- Commercial invoice
- Packing list
- Bill of lading / airway bill
- Certificate of origin (preferential where an FTA applies)
- Certificate of analysis
- Safety data sheet
- GMP certificate
- Written confirmation (EU) where applicable
- DMF letter of access / CEP copy on request
Frequently asked questions
What is the HS code for active pharmaceutical ingredients & intermediates exported from India?
Active Pharmaceutical Ingredients & Intermediates is usually classified under HS 2933 (Heterocyclic compounds with nitrogen hetero-atom(s) only (the largest API heading)). APIs spread across chapter 29 by chemistry: 2933/2934 heterocyclics, 2935 sulphonamides, 2936 vitamins, 2937 hormones, 2941 antibiotics, 2942 others. Classify per molecule.
Where is active pharmaceutical ingredients & intermediates produced in India?
Main clusters: Guntur (Asia's largest chilli yard) / Byadgi, Andhra Pradesh; Telangana; Karnataka; MP.
Which documents are needed to export active pharmaceutical ingredients & intermediates?
Commercial invoice, Packing list, Bill of lading / airway bill, Certificate of origin (preferential where an FTA applies), Certificate of analysis, Safety data sheet, GMP certificate. Destination-specific registrations are listed on each market page.
Do you have DMFs or CEPs?
We do not hold DMFs ourselves. We source from manufacturers who hold them and arrange a letter of access or CEP copy for qualified buyers.
Can I get samples before an audit?
Yes. Samples with a CoA are normally sent first, followed by a quality questionnaire, an audit and validation batches.
What packaging do APIs ship in?
Usually 25 kg fibre or HDPE drums with two LDPE liners, sealed and labelled with batch, manufacturing and retest dates.
Market guides
Get a quote for active pharmaceutical ingredients & intermediates
Share grade, quantity and destination port. We reply within one business day.